A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer
暂无分享,去创建一个
R. Verardo | S. Piazza | A. Leo | L. Malorni | I. Migliaccio | Y. Ciani | C. Biagioni | C. Guarducci | M. Bonechi | C. Hart | Yari Ciani | Silvano Piazza